Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues
about
Advances in pancreatic cancer research: moving towards early detectionChronic Pancreatitis: A ReviewConstruction of pancreatic cancer double-factor regulatory network based on chip data on the transcriptional level.Genome-scale analysis identifies GJB2 and ERO1LB as prognosis markers in patients with pancreatic cancer.Urine sample preparation in 96-well filter plates for quantitative clinical proteomics.Chemical composition and the potential for proteomic transformation in cancer, hypoxia, and hyperosmotic stressValidation of biomarkers that complement CA19.9 in detecting early pancreatic cancer.Recent developments in proteomic methods and disease biomarkers.LAMC2 enhances the metastatic potential of lung adenocarcinoma.Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer.Identification of molecular biomarkers for pancreatic cancer with mRMR shortest path methodProteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.Overcoming a species-specificity barrier in development of an inhibitory antibody targeting a modulator of tumor stroma.Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancerLAMC2 as a therapeutic target for cancers.Intravital biobank and personalized cancer therapy: the correlation with omics.Overexpression of LAMC2 predicts poor prognosis in colorectal cancer patients and promotes cancer cell proliferation, migration, and invasion.Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells.A functional polymorphism in lnc-LAMC2-1:1 confers risk of colorectal cancer by affecting miRNA binding.
P2860
Q24563998-0D160CA3-77AA-4EFE-9513-46F4AA3480DFQ28078379-2F447033-7D73-410A-AEE7-FEA9A93EC90CQ30743396-D2FE7FD1-0F32-4739-982D-610218A7F042Q33591508-57F45B00-0B0C-429A-B909-74E96D1EA022Q33710494-F1B7451C-3E37-4280-B749-BBE4F6A64640Q33777591-87E064D2-B530-414E-962A-A43F6DFE6445Q34518517-6744F554-BA5E-4B77-B697-5DF46316D436Q35197167-6893B084-BB6E-4065-BC24-B261042A7338Q35829871-7FB9CFD0-32D9-4FE3-8309-E827A4472F5AQ35909576-87FAE680-4AF8-4480-B9F3-7CD2553FD755Q38726982-D8B4C201-D80B-4C5F-B5E6-8206A9F8507BQ38777938-1EF4558F-80B2-464C-86C0-0EAF30FED4FFQ39102336-675FF241-8B39-4AE5-8030-C18C15824391Q42377458-A58B0C53-D55A-4B72-A115-FAFD84E99D56Q42461453-CE4DD88A-7477-4622-ACF7-3CA1B4ACCB5AQ47825939-95F2AD68-6121-4855-8AD1-1EF7A3099AC4Q47982337-7E0F181B-B4E3-4A34-B703-1063CB58557AQ52616966-0DD7DED4-C6B5-4BE1-8219-AF704C1346EAQ53205914-01B7D295-614C-448E-B0D2-2393F0FC0C9D
P2860
Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Laminin, gamma 2 (LAMC2): a pr ...... creatic adenocarcinoma tissues
@en
Laminin, gamma 2 (LAMC2): a pr ...... reatic adenocarcinoma tissues.
@nl
type
label
Laminin, gamma 2 (LAMC2): a pr ...... creatic adenocarcinoma tissues
@en
Laminin, gamma 2 (LAMC2): a pr ...... reatic adenocarcinoma tissues.
@nl
prefLabel
Laminin, gamma 2 (LAMC2): a pr ...... creatic adenocarcinoma tissues
@en
Laminin, gamma 2 (LAMC2): a pr ...... reatic adenocarcinoma tissues.
@nl
P2093
P2860
P50
P356
P1476
Laminin, gamma 2 (LAMC2): a pr ...... creatic adenocarcinoma tissues
@en
P2093
Alison Chan
Apostolos Dimitromanolakis
Eleftherios P Diamandis
Felix Rückert
Ioannis Prassas
Ireena Soleas
Masato Maekawa
Randall Brand
Robert Gruetzmann
P2860
P304
P356
10.1074/MCP.M112.023507
P577
2013-06-24T00:00:00Z